Oridonin Alters Hepatic Urea Cycle via Gut Microbiota and Protects against Acetaminophen‐Induced Liver Injury
Mukeng Hong, Haihua Liu, Guihong Chen, Junqing Zhu, Songyuan Zheng, Di Zhao, Jianxing Diao, Hui Jia, Dingding Zhang, Shixian Chen, Lei Gao, Juan Li
Abstract
Acetaminophen (APAP) hepatotoxicity is the leading cause of acute liver failure in the western world. Oridonin (OD), which is the major active ingredient of the traditional Chinese medicine Rabdosia rubescens , reportedly exerts anti‐inflammatory and antioxidative effects. Here, we first find that OD protects against APAP‐induced hepatotoxicity. The results of hepatic tissue‐associated RNA‐seq and metabolomics showed that the protective effects of OD were dependent upon urea cycle regulation. And such regulation of OD is gut microbiota partly dependent, as demonstrated by fecal microbiota transplantation (FMT). Furthermore, using 16S rRNA sequencing, we determined that OD significantly enriched intestinal Bacteroides vulgatus , which activated the nuclear factor erythroid 2‐related factor 2 (Nrf2) pathway to regulate redox homeostasis against APAP by urea cycle. In conclusion, our study suggests that the Bacteroides vulgatus ‐urea cycle‐Nrf2 axis may be a potential target for reducing APAP‐induced liver injury, which is altered by OD.